Treatment with anti-vegf antibodies
AssigneeGenentech, Inc.
InventorsGwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
Life of this patent
Estimating the term…
Abstract
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
Claims9
A method of treating a carcinoid carcinoma in a human patient, comprising administering to the patient effective amounts of an anti-VEGF antibody, wherein said anti-VEGF antibody is bevacizumab, and an at least one anti-neoplastic composition, wherein said anti-neoplastic composition comprises at least one chemotherapeutic agent.
Dependencies are inferred from the claim text.